Additionally, flow cytometry on a subset of our full cohort of BM aspirates (Fig. 1A, Supplementary Fig. 1A; n = 22) further validated the presence of iMSCs in CHIP and MDS using CD44 and CD51/61 markers. The gene discussed is CD44; the disease is myelodysplastic syndrome.